Skip to main content
Premium Trial:

Request an Annual Quote

New Product Watch: Sep 8, 2009

Premium

Cytoo this week launched its CytooChip micropattern array platform for high-content screening of cells.

According to the Grenoble, France-based firm, the CytooChip platform can be used to study a number of phenomena, including cell signaling, cell adhesion and polarity, cell division, and precise protein co-localization.


Amsbio recently began offering frozen tissue arrays for validating potential biological targets in diagnostics, therapeutics, and the studies of protein markers and genes.

According to the Abingdon, UK firm, the tissue arrays are manufactured using fresh frozen tissues identified by a board-licensed pathologist and prepared on positively charged glass slides. Each frozen tissue array can contain up to 40 different normal adult human tissue types with three donors per tissue type, Amsbio said.

The company also allows customers to design custom human tissue arrays for target expression and biomarker analysis in diseased and normal tissues.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.